Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first outbreak of cVDPV was identified in the Dominican Republic and Haiti between 2000 and 2001.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“In general, the VP1 sequences examined from cVDPV isolates differed from parental OPV strains by only 1–3.5%, suggesting that reversion to the attenuated phenotype of Sabin strains occurs with circulation times of 1–4 years [91,92,93,95,100].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“As with the other epidemics in Egypt and Hispaniola, VDPV circulated in a province of Madagascar with low OPV coverage (6,7).”
From Recombinant Vaccine–Derived Poliovirus in Madagascar (2003) · cites this paper as [7]
In the citing paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
From Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar (2007) · cites this paper as [12]
In the citing paper
“The cVDPV had recovered two of the most important biological properties of wild PV: the capacity to cause severe paralytic disease in humans and the capacity for extensive human-to-human transmission.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [83]
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Self-citationStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationKawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157
Self-citationDeterminants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationMinor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120
Research works printed but not linked: 5
- Andrus J. K., Strebel P. M., de Quadros C. A., Olive J. M., Bull. WHO 73, 33 (1995).
- Supplementary figures and details of experimental procedures are available on Science Online at www.sciencemag.org/cgi/content/full/1068284/DC1.
- Minor P. D., Curr. Top. Microbiol. Immunol. 161, 121 (1990).
- ___, Morb. Mortal. Wkly. Rep. 50, 41 (2001).
- Wood D. J., Sutter R. W., Dowdle W. R., Bull. WHO 78, 347 (2000).
Cited by
Items 501–594 of 594
Increasing polio coverage with safer vaccines: a pressing need in Latin America
Falleiros-Arlant, L. H., Torres, J. R., Avila-Aguero, M. L., del Castillo, J. B., de Gentile, A. S., & Debbag, R. (2022) · Revista chilena de infectología · doi:10.4067/s0716-10182022000500614 · Cited by 2
Poliomielite e seu controle pela imunização
Waldman, E. A. (2019) · Editora FIOCRUZ eBooks · doi:10.7476/9786557080627.0003 · Cited by 1
Achievements and obstacles in the late phase of the global polio eradication initiative
Müller, O., Lu, G., Meissner, P. E., von Seidlein, L., Jahn, A., & Razum, O. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0079 · Cited by 4
Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread
Cândido, D. D. S., Dellicour, S., Cooper, L., Junior, C. A. P., Jorgensen, D., Uzzell, C. B., Voorman, A., Lyons, H. M., Klapsa, D., Majumdar, M., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02174-6 · Cited by 2
“In rare instances, vaccine strains can acquire mutations associated with paralysis and transmissibility and subsequently lead to outbreaks caused by circulating VDPV (cVDPV) 3,7,8 .”
Rousset, D., Andrianarivelo, M. R., Razafindratsimandresy, R., Balanant, J., & Delpeyroux, F. (2004) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(04)90021-2 · Cited by 1
Nates, S. V., FRIAS, M., Belfiore, S. M., Isa, M. B., Martínez, L. C., Chuit, R., Armoni, J., & Luxemburger, C. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810001512 · Cited by 2
“These VDPVs have been at the origin of several localized outbreaks [14, 15].”
BackgroundMolecular Analysis of Enterovirus C Species Using the 5’ Untranslated Region and VP1 Region
Zhou, F. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00038 · Cited by 1
“Moreover, from 1963 to 1966, widespread circulation of VDPVs took place in a region of Byelorussia (BYE) [18].”
BackgroundInfluentialNecessity of Two-Stool Sample Test for Sensitive Detection of Poliovirus
Yoneyama, T., Yoshida, H., Yoshii, K., Wada, J., Shimizu, H., & Miyamura, T. (2002) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2001.250 · Cited by 1
Self-citationOBSOLETE: Re-emerging Diseases: Overview
Wilson, M. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02835-x · Cited by 1
Olaoye, I., Fatiregun, A. A., Opeyemi, E., Adeleke, D., Jacdonmi, T., Fagbemi, S. O., Famokun, G. A., Samuel, A., Akinpelumi, A. V., & Onyibe, R. I. (2021) · International Journal of Epidemiology and Health Sciences · doi:10.51757/ijehs.2.12.2021.246984 · Cited by 1
Current Status and Future of Polio Vaccines and Vaccination
Chumakov, K. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1818-4_4 · Cited by 1
Modlin, J. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00171-5 · Cited by 1
Comparative Study on MNVT of OPV Type I and III Reference Products in Different Periods
Wang, X., Ren, R., Ma, B., Xie, J., Ma, Y., Luo, H., Guo, Y. D., Ding, L., Zhang, L., Zhang, M., et al. (2023) · Diseases · doi:10.3390/diseases11010028 · Cited by 1
Vaccine-derived poliovirus type 3 emergence in Guinea, 2024
Faye, M., Ndiaye, N., Kouadjo, E. K., Camara, S. A., Solano, S., Kébé, O., Leno, N. N., Modibo, B., Keita, D., Diakité, B., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00017-9 · Cited by 1
Global situation for poliomyelitis. Who strategy and tactics of global polio eradication
Бичурина, М. А., Romanenkova, N. I., Rozaeva, N. R., & Vorotnikova, V. A. (2014) · Journal Infectology · doi:10.22625/2072-6732-2011-3-2-5-14 · Cited by 1
Utama, A., & Shimizu, H. (2007) · Microbiology Indonesia · doi:10.5454/mi.1.3.6 · Cited by 1
“Recombination of OPV and circulating wild-type PV was reported in China (Liu et al. 2000; Liu et al. 2003), and recombination of OPV and circulating non-polio enteroviruses were reported in the Dominican Republic and Haiti (Kew et al. 2002), in Madagascar (Rousset et al. 2003), in Egypt (Yang et al. 2003), and in the…”
BackgroundSelf-citationRiddell, A., & Pollard, A. J. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.1.105 · Cited by 1
Caraș, I., Ţucureanu, C., Lerescu, L., & Sălăgeanu, A. (2007) · PubMed · Cited by 1
Wilton, T. (2012) · doi:10.25560/10677 · Cited by 1
The molecular determinants and consequences of recombination in the evolution of human enteroviruses
Lowry, K. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33607165 · Cited by 1
Research and Development of Chimeric Flavivirus Vaccines
Delagrave, S., & Guirakhoo, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-569-5_49 · Cited by 1
Boot, H. J., Lukashov, V. V., van Remmerden, Y., & Kimman, T. G. (2006) · Virus Genes · doi:10.1007/s11262-006-0012-9 · Cited by 1
Inactivated poliovirus vaccine: The fog of uncertainty is lifting!
John, T. J. (2012) · Indian Pediatrics · doi:10.1007/s13312-012-0179-1 · Cited by 1
“In serial replication in humans, VPVs de-attenuate and become ‘vaccine-derived polioviruses’ (VDPVs) [2].”
BackgroundFacilitating viral recombination
Griffiths, P. D. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.374 · Cited by 1
Virus émergents ou menaces à répétition
Lina, B. (2005) · Antibiotiques · doi:10.1016/s1294-5501(05)80175-x · Cited by 1
“Il s’agit de virus dont le génome est dérivé de 2 ou 3 souches de poliovirus prototypes [21] ou de recombinaison génétique entre le génome d’un poliovirus et celui d’un entérovirus non polio [22].”
Surveillance of Poliovirus-Isolates in Japan, 2002
Shimizu, H., Yoshida, H., Utama, A., Nakayama, T., Saito, T., Watanabe, K., Iizuka, S., Noda, S., Yoneyama, T., & Miyamura, T. (2003) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2003.218 · Cited by 1
“However, poliomyelitis outbreaks associated with circulating vaccine-derived polioviruses (cVDPVs) have been identified in Egypt (19881993), Hispaniola (2000 - 2001), the Philippines (2001), and Madagascar (2001-2002) (3-6).”
BackgroundSelf-citationRe-emerging Diseases: Overview
Wilson, M. E. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00461-5 · Cited by 1
Minor, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-012374410-4.00722-6 · Cited by 1
Kew, O. M., & Nathanson, N. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr427 · Cited by 1
Self-citationJohn, T. J., Dharmapalan, D., Steinglass, R., & Hirschhorn, N. (2025) · Qeios · doi:10.32388/x0n956 · Cited by 1
Auguet, O. T. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Oral Vaccination: Attenuated and Gene-Based
Peters, W., Scallan, C. D., & Tucker, S. N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5380-2_4
Structural studies on members of the picornavirus superfamily
Seitsonen, J. J. T. (2011) · Työväentutkimus Vuosikirja
Molecular epidemiology of human rhinoviruses
Savolainen‐Kopra, C. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 1
Design and Development of Recombinant Vaccines with Viral Properties
Lipowsky, G., & Bachmann, M. F. (2011) · Wiley eBooks · doi:10.1002/9781118023648.ch2
Peptide profiling of the route from Mahoney to Sabin, and return
Kanduc, D., Fasano, C., Bavaro, S. L., Novello, G., Lucchese, G., & Capone, G. (2013) · Journal of Basic Microbiology · doi:10.1002/jobm.201200642 · Cited by 1
Quantitative analysis of trade-offs and model input sensitivities in public health
Tebbens, R. J. D. (2005)
Generation and Characterization of Temperature Resistant Mutant of Recombinant PJ156/CAV-17 Virus
Utama, A., & Shimizu, H. (2007) · Microbiology Indonesia · doi:10.5454/mi.1.2.8
“…incidents of paralytic poliomyelitis outbreaks due to circulating vaccine-derived poliovirus (cVDPV) were reported; respectively in the Dominican Republic and Haiti (Kew et al. 2002), the Philippines (Shimizu et al. 2004), in Egypt (Yang et al. 2003), and in Madagascar (Rousset et al. 2003).”
BackgroundSelf-citationSule, W. F., Oyedele, O. I., Osei-Kwasi, M., Odoom, J. K., & Adu, F. (2009) · East African Medical Journal · doi:10.4314/eamj.v85i3.9632
“When changes in the OPV viruses resulted in re-acquisition of transmissibility and neurovirulence, like their wild counterparts (2,18) they may induce paralytic disease called vaccine-associated paralytic poliomyelitis (VAPP) in OPV recipients and in their susceptible contacts (19).”
BackgroundÖzkaya, E., Ishiko, H., Miura, R., Shimada, Y., Alàeddínoğlu, I., Artuk, C., Miyamura, K., & Yamazaki, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.19653-0
“In addition, nucleotide sequence analysis has become an essential procedure following the emergence and circulation of vaccine-derived polioviruses associated with poliomyelitis cases (Kew et al., 2002).”
BackgroundPost-polio eradication: vaccination strategies and options for India
Thayyil, J., & Jayakrishnan, T. (2014) · Healthcare in Low-resource Settings · doi:10.4081/hls.2014.1978
Polio vaccines and the eradication of poliomyelitis
O’Reilly, K. M. (2012)
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.003
Razafindratsimandresy, R., Rakoto Andrianarivelo, M., & Rousset, D. (2003) · Archives de l'Institut Pasteur de Madagascar
Dimitriou, T. G., Kyriakopoulou, Z., Tsakogiannis, D., Fikatas, A., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2016) · Virus Genes · doi:10.1007/s11262-016-1333-y
Molecular Analysis of Enteroviruses
Zhou, F. (2016) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2016.03.00083
“Recombination can occur between PVs and other EV-C viruses within the 5’ UTR and non-structural coding regions; this shuffling of different non-structural coding regions may lead to serotypes with selective advantages [3,46,120].”
BackgroundInfluentialStochastische Modellierung von Exitstrategien der Poliomyelitis
Krampol, M. (2007)
Improving the immunogenicity of recombinant adeno-associated virus
Ussher, J. E. (2010) · ResearchSpace (University of Auckland)
Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.018
Bart, K. J., Lin, F. C., Liu, D., & Kuo, H. (2010) · Epidemiology bulletin
Development of a DNA vaccine inducing HIV-1 Gagp24-reactive T cells
Guo, S. (2016) · NORA - Norwegian Open Research Archives
OBSOLETE: Historical Poliomyelitis
van Vliet, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02989-5
Avila-Aguero, M. L. (2018) · Revista chilena de infectología · doi:10.4067/s0716-10182018000400341
Biologicals, Including Vaccines
Thea, S., & Minor, P. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813697-3.00025-1
Santoni, J. R., Garib, Z., Mancebo, P., Santoni, C., Grullón, P., & Rodríguez, A. (2018) · Ciencia y Salud · doi:10.22206/cysa.2018.v2i3.pp9-17
Self-citationPROBLEMS OF FINAL PHASE POLIOMYELITIS ERADICATION PROGRAMME
Chernyavskaya, O. P., & Briko, N. I. (2017) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2017-4-75-81
Vashishtha, V. M., & Gupta, P. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.01.005
Review of: "Polio eradication at the crossroads"
John, T. J., & Dharmapalan, D. (2021) · doi:10.32388/c8kbfu
Wilson, M. E., & Chen, L. H. (2008) · Elsevier eBooks · doi:10.1016/b978-012370466-5.50006-6
“China 3 Korea 1 Japan 4 Pakistan 3 Philippines 3 Singapore 1 Tahiti 1 Tonga 1 Vietnam 1 Asia Albania 1 France 3 Germany 8 Italy 8 Spain 1 Switzerland 5 Ukraine 1 Europe Ethiopia 1 South Africa 1 Africa Ch01-P370466.indd 36 11/23/07 10:13:10 AM Travel 37 resident traveler.”
Shulman, L. M. (2020) · Springer eBooks · doi:10.1007/978-1-4939-2493-6_839-3
Rowlands, D. J., & Minor, P. D. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch27
(2014) · ASM Press eBooks · doi:10.1128/9781555817510.refs
Minor, P. D. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0246
Nelson, K. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198569541.003.0021
Minor, P. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02645-3
Minor, P. D. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0001081.pub3
van Vliet, H., van der Avoort, H., & Spaendonck, M. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00336-2
van Vliet, H., van der Avoort, H., & Spaendonck, M. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00379-8
Minor, P. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814515-9.00123-5
Bradrick, S. S., Romero, J. R., & Minor, P. D. (2009) · Wiley eBooks · doi:10.1002/9780470015902.a0001081.pub2
The Mechanism, Progress, and Potential Problems behind Different Types of COVID-19 Vaccines
Wang, Y., & Wu, Z. (2022) · International Conference on Biotechnology, Life Science and Medical Engineering (BLSME) · doi:10.23977/blsme.2022050
“Live attenuated vaccine stands longer, but there was a record that oral polio vaccine arose an outbreak of paralytic poliomyelitis from 2000 to 2001 in the Dominican Republic [7].”
BackgroundShulman, L. M. (2023) · Encyclopedia of sustainability science and technology series · doi:10.1007/978-1-0716-2463-0_839
Kew, O. M. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_13-1
Self-citationvan der Vliet, H. J., van der Avoort, H., Spaendonck, M. C., Ruijs, H., & Duizer, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00077-6
Chansaenroj, J., & Poovorawan, Y. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.361
Diversity and molecular characterisation of enteroviruses detected in Hungary
Bujáki, E. (2023) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2022.150
Protocolo de vigilancia en salud pública. Parálisis flácida aguda
Pública, D. D. V. Y. A. D. R. E. S. (2024) · doi:10.33610/uqeg9792
Enterovirus and parechovirus infections
Krogstad, P. A., & Cherry, J. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00035-4
Re-Emerging Diseases: Overview
Wilson, M. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00311-2
Informe de Evento 2023. Parálisis Flácida Aguda
Salud, G. E. T. P. P. V. Y. R. C. L. A. E., Rodríguez, Y. M. E., Subdirección de Prevención, V. Y. C. E. S. P., & Pública, D. D. V. Y. A. D. R. E. S. (2022) · doi:10.33610/infoeventos.42.1
Sauthier, J. T., Dias, J. B., Ferreira, C. D. S., Gomes, B. D. O. N., Fraga, K. A., Gonçalves, I. M. D. S., de Souza, A. A. A., dos Santos, A. A. C., Müller, B. D. L. A., Lima, L. F., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5180131
Vaccins contre la poliomyélite : de la solution au problème
Lelièvre, J. (2025) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(25)76352-2 · Cited by 1
Zhang, W. Y., Yan, D., Zeng, H., Zhou, L., Zheng, H., Zhu, S., Zhang, Y., & Li, B. (2025) · Virology Journal · doi:10.1186/s12985-025-02827-2
Molecular ingredients of an immunogen for long-lasting IgG
Gupta, S. L., Meyer, A. R., Kay-Tsumagari, E., & Cheng, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1639371
Tracking poliovirus through wastewater: environmental surveillance insights from Haïti (2020–2023)
Belgasmi, H., Hill, J., Miles, S. J., Sayyad, L., Elahi, H., Patterson, N. E., Deas, A., Heberlienne, A., Wilkinson, A. L., Vega, E. M., et al. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.01179-25 · Cited by 1
“Haïti, located in the Hispaniola Island, characterized by persistently low polio immunization coverage, poor sanitation infrastructure, and a cVDPV1 outbreak in 2000–2001, has been among PAHO’s priority countries for ES implementation (32–34).”
Self-citationΑνασυνδυασμένα στελέχη πολιοϊών - θέσεις γενετικού ανασυνδυασμού
Paximadi, E. (2009) · doi:10.12681/eadd/17217
Al-Qassimi, M. A., Al Amad, M., Anam, L., Almoayed, K. A., Al-Dar, A., & Ezzadeen, F. H. (2022) · Figshare · doi:10.6084/m9.figshare.19687004
Medkour, H. (2020) · theses.fr (ABES) · doi:10.70675/58a94f04z314bz4dccz923dz78a302d8cca3
Bakyono, B. S., Mirand, A., Neuner-Jehle, N., Andrés, C., Vila, J., Antón, A., Schuffenecker, I., Jeannoël, M., Josset, L., Landaas, E. T., et al. (2026) · Virus Evolution · doi:10.1093/ve/veag051
“…the first well-documented outbreak of vaccine-derived paralysis, four independent type 1 vaccine-derived recombinant polioviruses were identified ( Kew et al. 2002); these carried the 5 UTR and capsid regions of Sabin type 1 recombined with non-structural region fragments from other enterovirus C…”
Gerloff, N. A., Sun, H., Short, B., Harvey, E., Miles, S. J., Marcet, P. L., Poston, K. D., Castro, C. J., Nix, W. A., Alam, M. M., et al. (2026) · Journal of Clinical Microbiology · doi:10.1128/jcm.00658-26
“VDPVs type 1 and type 3 are defined as having >1% nucleotide (nt) sequence divergence (i.e., ≥10 nt substitutions) from Sabin strains in the ~900 nt capsid protein region VP1 (10).”
Prevalence and Genetic Diversity of Human Enteroviruses in the Context of Poliovirus Eradication
van der Sanden, S. (2012) · Rivm Repository (Netherlands National Institute for Public Health and the Environment)
Polio Reemerges in the Americas: a Vaccine-Derived Outbreak in Hispaniola in 2000 and 2001
de Quadrós, C. A., Landaverde, M., Kew, O. M., Garib, Z., André, J., Pedreira, C. C., & Laender, F. (2014) · ASM Press eBooks · doi:10.1128/9781555816995.ch2
Self-citation
Metadata
- Authors
- Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M., & de Quadros, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
- World Health Organization Regional Office for the Americas (US)
- Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
- Ministry of Public Health, Port-au-Prince, Haiti.
- PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
- PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
- National Institute of Infectious Diseases (JP)
- Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
- Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
- Corresponding author
- Kew, Olen
- ORCID
- Venue
- Science
- Published
- 2002-04-12
- Volume
- 296
- Issue
- 5566
- Pages
- 356-359
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101037145
- Cited by
- 600
- References
- 19
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 26 · 2015: 22 · 2014: 39 · 2013: 26 · 2012: 26
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- poliomyelitis outbreak, vaccine-derived poliovirus, poliovirus type 1, oral polio vaccine, Hispaniola, Dominican Republic, Haiti, unvaccinated children, low vaccination coverage, paralytic poliomyelitis, wild poliovirus
- MeSH terms
- Adolescent, Animals, Capsid, Child, Child, Preschool, Disease Outbreaks, Dominican Republic, Female, Genes, Viral, Haiti, Humans, Infant, Male, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Recombination, Genetic, Vaccination, Virulence, Point Mutation, Immunization Programs, Poliovirus, 5' Untranslated Regions, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.